<?xml version="1.0" encoding="utf-8"?>
	<collection>
		
	
		<source>SourceData</source>
		
	
		<date>2019-06-24</date>
		
	
		<key>sourcedata.key</key>
		
	
		<document>
			
		
			<id>5090663 Figure_1-A-1</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-A-1</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-A-1</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A) Proliferation analysis of hematopoietic CD34+ precursors for up to 6 days (section i).</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">Uniprot:Q64314</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="44"/>
					
				
					<text>CD34</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-A-2</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-A-2</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-A-2</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A) Neutrophil morphologic differentiation were assessed at day 6 (section ii). Controls were without treatment. White arrows indicate neutrophilnuclear segmentation. A+G, Am80-GCSF combination; CL, chemiluminescence; RLU, relative light units; AUC, area under the curve.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-A-3</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-A-3</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-A-3</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A) Neutrophil bacterial killing were assessed at day 6 (section iii). Controls were without treatment. . A+G, Am80-GCSF combination; CL, chemiluminescence; RLU, relative light units; AUC, area under the curve.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-A-4</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-A-4</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-A-4</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A) Neutrophil ROS production were assessed at day 6 (iv). Controls were without treatment. A+G, Am80-GCSF combination; CL, chemiluminescence; RLU, relative light units; AUC, area under the curve.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-B</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(B) qRT-PCR assessed RA-target gene expression after culturing CD34+ cells for 1, 2, and 6 days.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">Uniprot:Q64314</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="63"/>
					
				
					<text>CD34</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-C</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(C) Flow cytometry analysis of CD66-CD18 co-expression after culturing CD34+ cells for 6 days, using anti-human CD66-PE and CD18-FITC antibodies (section i). Isotypes were used for controls (section i, top panel). CD66-CD18 co-expression was quantified in section ii.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:CD66</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="31"/>
					
				
					<text>CD66</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:CD66</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="4" offset="112"/>
					
				
					<text>CD66</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:CD66</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="4" offset="214"/>
					
				
					<text>CD66</text>
					
			
				</annotation>
				
			
				<annotation id="4">
					
				
					<infon key="type">Uniprot:P05107</infon>
					
				
					<infon key="sourcedata_figure_annot_id">4</infon>
					
				
					<infon key="sourcedata_article_annot_id">4</infon>
					
				
					<location length="4" offset="36"/>
					
				
					<text>CD18</text>
					
			
				</annotation>
				
			
				<annotation id="5">
					
				
					<infon key="type">Uniprot:P05107</infon>
					
				
					<infon key="sourcedata_figure_annot_id">5</infon>
					
				
					<infon key="sourcedata_article_annot_id">5</infon>
					
				
					<location length="4" offset="124"/>
					
				
					<text>CD18</text>
					
			
				</annotation>
				
			
				<annotation id="6">
					
				
					<infon key="type">Uniprot:P05107</infon>
					
				
					<infon key="sourcedata_figure_annot_id">6</infon>
					
				
					<infon key="sourcedata_article_annot_id">6</infon>
					
				
					<location length="4" offset="219"/>
					
				
					<text>CD18</text>
					
			
				</annotation>
				
			
				<annotation id="7">
					
				
					<infon key="type">Uniprot:Q64314</infon>
					
				
					<infon key="sourcedata_figure_annot_id">7</infon>
					
				
					<infon key="sourcedata_article_annot_id">7</infon>
					
				
					<location length="4" offset="71"/>
					
				
					<text>CD34</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-D-5</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-D-5</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-D-5</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Fresh peripheral blood (PB) collected from normal human donor. Bacterial killing was assessed in the presence or absence of PBneutrophils (section i).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-D-6</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-D-6</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-D-6</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Fresh peripheral blood (PB) collected from normal human donor. Bactericidal activities of neutrophils induced by Am80-GCSF from PB mononuclear cells were evaluated by ROS production (section ii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-D-7</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-D-7</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-D-7</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Fresh peripheral blood (PB) collected from normal human donor. Bactericidal activities of neutrophils induced by Am80-GCSF from PB mononuclear cells were evaluated by bacterial killing assays (section iii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-E</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-E</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-E</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(E) Fresh PB neutrophils collected from normal human donor were tested for ROS production in the presence or absence of specific antibodies. Controls were with or without IgG. Normal IgG, Ï†; Ab, antibodies; Comb Ab, combined anti-CD18 and -CD11b antibodies.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Comb Ab</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="7" offset="208"/>
					
				
					<text>Comb Ab</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">Uniprot:P05555</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="5" offset="241"/>
					
				
					<text>CD11b</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">Uniprot:P05107</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="4" offset="231"/>
					
				
					<text>CD18</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_1-F</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 1-F</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-F</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(F) Fresh PB mononuclear cells collected from normal human donors were treated for 3 days. Bacterial killing (sections i) and neutralization of bacterial killing in the presence of IgG or anti-CD18 antibody were assessed at day 3 (section ii).</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">Uniprot:P05107</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="193"/>
					
				
					<text>CD18</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_2-A-1</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 2-A-1</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-A-1</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A) Fresh bone marrow mononuclear cells were collected from acute myeloid leukemia (AML) patient. Proliferation (section i) were analyzed after cells were treated for 4 days.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_2-A-2</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 2-A-2</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-A-2</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A) Fresh bone marrow mononuclear cells were collected from acute myeloid leukemia (AML) patient. ROS production (section ii) were analyzed after cells were treated for 4 days.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_2-B-3</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 2-B-3</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-B-3</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(B) Fresh BM mononuclear cells collected from AML patient were treated for up to 6 days. Transcription of RA-target genes was analyzed with qRT-PCR at day 2, 3, and 6 (sections i).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_2-B-4</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 2-B-4</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-B-4</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(B) Fresh BM mononuclear cells collected from AML patient were treated for up to 6 days. Proliferation was assessed at day 3 in parallel (section ii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_2-B-5</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 2-B-5</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-B-5</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(B) Fresh BM mononuclear cells collected from AML patient were treated for up to 6 days. ROS production were assessed at day 3 in parallel (section iii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_3-A</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 3-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A) Fresh BM mononuclear cells collected from AML patients were treated with 20 or 50 nM Am80 alone or combined with medium dose of GCSF (25 ng/ml) for up to 9 days. Dynamic changes in proliferation (left sections) and live cells on day 9 (right sections) were illustrated for each of specimens. Controls were without treatment.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">Uniprot:P09920</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="132"/>
					
				
					<text>GCSF</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_3-B</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 3-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(B) Fresh PB or BM mononuclear cells collected from AML patients were treated with 20, 100, or 150 nM Am80 alone or combined with GCSF for up to 12 days. Dynamic changes in proliferation (left sections) and live cells on day 12 (right sections) were illustrated for each of specimens.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">Uniprot:P09920</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="130"/>
					
				
					<text>GCSF</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_3-C</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 3-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(C) Fresh BM mononuclear cells collected from AML patients were treated with 150 nM Am80 alone or combined with GCSF. Proliferation (left sections) and bacterial killing (right sections) were analyzed on day 12 for each of samples.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_3-D-1</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 3-D-1</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-D-1</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Fresh BM mononuclear cells collected from AML patient were treated with 150 nM Am80 alone or combined with GCSF. Proliferation was assessed for up to 12 days (section i).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_3-D-2</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 3-D-2</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-D-2</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(B) Fresh BM mononuclear cells collected from AML patients were treated with 20, 100, or 150 nM Am80 alone or combined with GCSF for up to 12 days. ROS production was assessed at day 12 (section ii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_3-D-3</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 3-D-3</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-D-3</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Fresh BM mononuclear cells collected from AML patient were treated with 150 nM Am80 alone or combined with GCSF. Bacterial killing was assessed at day 12 (sections iii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_3-D-4</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 3-D-4</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-D-4</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Fresh BM mononuclear cells collected from AML patient were treated with 150 nM Am80 alone or combined with GCSF. Morphologic differentiation was assessed at day 12 (section iv). White arrows indicate neutrophil nuclear segmentation.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_3-D-5</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 3-D-5</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-D-5</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Fresh BM mononuclear cells collected from AML patient were treated with 150 nM Am80 alone or combined with GCSF. RA-target gene expression was assessed at day 12 (section v).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_4-A</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 4-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A) Mouse CCIN induced by cancer chemotherapy drug cyclophosphamide (CPA) consists of both neutrophil decrease and neutrophil recovery stages. ANC, absolute neutrophil count.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:cpa</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="69"/>
					
				
					<text>CPA</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_4-D</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 4-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Vetscan counting PBleukocytes.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_4-E</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 4-E</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-E</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(E) Neutrophils induced by low dose treatment in PB (section i) and BM (section ii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_4-F</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 4-F</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-F</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(F) Bacterial killing by PB neutrophils was assessed at 3 and 16 hr post-infection and in spleen (sections i-iii), using blood agar analysis of total extracellular viable bacteria.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_4-H</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 4-H</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-H</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(H) Vetscan counting PB leukocytes.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_4-I</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 4-I</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-I</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(I) Neutrophils induced by medium dose treatment in PB (section i) and BM (section ii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_4-J</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 4-J</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-J</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(J) Similar to panel F, bacterial killing by PBneutrophils was evaluated 3 and 16 hr post-infection and in heart.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_5-B</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 5-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(B) Vetscan counting PB leukocytes.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_5-C</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 5-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(C) Bacterial killing by PB neutrophils was evaluated 3 and 16 hr post-infection (sections i, ii), using blood agar analysis of extracellular viable bacteria.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_5-D-E</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 5-D-E</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-D-E</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D &amp;amp; E) Neutrophil recovery and morphologic differentiation induced by low doses of Am80 and/or GCSF in BM (panel D) and PB (panel E). White arrows indicate neutrophil nuclear segmentation.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">Uniprot:P09920</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="96"/>
					
				
					<text>GCSF</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_6-B</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 6-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(B) Survival of CCIN mice was calculated with both Kaplan-Meier plots and log-rank test on day 9 since CPA injection (section i) as well as assessed 6 days post-infection (section ii). Data represent 3 independent experiments with similar results.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">gene:CCIN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="16"/>
					
				
					<text>CCIN</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:cpa</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="3" offset="103"/>
					
				
					<text>CPA</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_6-C</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 6-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(C) Gram and Giemsa stains analyzed neutrophil phagocytosis and bacterial clearance in mice surviving on day 9. White arrows indicate phagocytosed S. aureus in neutrophils.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_6-E</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 6-E</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-E</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(E) Survival of CCIN mice was calculated with both Kaplan-Meier plots and log-rank test on day 9 since CPA injection (section i) as well as assessed 6 days post-infection (section ii). Data represent 2 independent experiments with similar results.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">gene:CCIN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="16"/>
					
				
					<text>CCIN</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:cpa</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="3" offset="103"/>
					
				
					<text>CPA</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_6-G</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 6-G</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-G</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(G) Survival of CCIN mice was calculated with both Kaplan-Meier plots and log-rank test on day 9 since CPA injection (section i) as well as assessed 6 days post-infection (section ii).</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">gene:CCIN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="16"/>
					
				
					<text>CCIN</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:cpa</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="3" offset="103"/>
					
				
					<text>CPA</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_7-A-B</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 7-A-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_7-A-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(A &amp;amp; B) Neutrophil recovery and morphologic differentiation were assessed in BM (panel A) and PB (panel B) of CCIN mice surviving on day 9. White arrows indicate neutrophil nuclear segmentation.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">gene:CCIN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="110"/>
					
				
					<text>CCIN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_7-C-1</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 7-C-1</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_7-C-1</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(C) PBneutrophil production and nuclear segmentation were assessed in control and Am80-GCSF mice surviving on day 13 (section i).</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">gene:Am80</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="82"/>
					
				
					<text>Am80</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_7-C-2</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 7-C-2</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_7-C-2</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(C) PBneutrophil production and nuclear segmentation were assessed in control and Am80-GCSF mice surviving on day 13 (section ii).</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">gene:Am80</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="82"/>
					
				
					<text>Am80</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_7-C-3</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 7-C-3</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_7-C-3</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(C) The increased spleen size on day 9 in Am80-GCSF mice dropped to the levels similar to those in control mice on day 13 (section iii).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_7-C-4</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 7-C-4</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_7-C-4</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(C) The increased spleen weight on day 9 in Am80-GCSF mice dropped to the levels similar to those in control mice on day 13 (sections iii, iv).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_7-D</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 7-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_7-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(D) Significant loss of body weight occurred in GCSF mice on day 9.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">Uniprot:P09920</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="48"/>
					
				
					<text>GCSF</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5090663 Figure_7-E</id>
			
		
			<infon key="sourcedata_document">2344</infon>
			
		
			<infon key="doi">10.15252/emmm.201606434</infon>
			
		
			<infon key="pmc_id">5090663</infon>
			
		
			<infon key="figure">Figure 7-E</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_7-E</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>(E) Ultrastructure analysis of neutrophils collected from mice surviving on day 11. Neutrophil from GCSF mice showed less granules (section i, images 1 vs. 2 or 3), more intracytoplasmic vacuoles (sections i, ii), and inner nuclear membrane dilation (sections i, iii). Pg: primary granules; Sg: secondary granules.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">Uniprot:P09920</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="100"/>
					
				
					<text>GCSF</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		

	</collection>
